Tag: VIVE

Blue Horseshoe Stocks: Killing it On the Options Front

Killing it On the Options Front 

It seems each time we put out new ideas for potential options trades, tjhat we are met with instant success. Such has been the case for the last several calls as it seems we identify winners much more often than not. Most recently, yesterday morning in our premarket report, we highlighted some possible plays in TGT nand LOW, and they both turned in a winning card on the day.

Here are the trading ranges and total possible single-session profits that were available to anyone who happened to act on our suggestions:

TGT Weekly $98-101 Calls  
$98 Calls – Range: 2.18-5.40 – Max Gain: 128%
$99 Calls – Range: 1.64-4.35  – Max Gain: 166%
$100 Calls – Range: 1.20-3.63 – Max Gain: 203%
*$101 Calls – Produced similar gains, however we were unable to pull up the corresponding data.

Update: We want to roll up and monitor the TGT Weekly $103-104 Calls into the end of the week. 
_____

LOW Weekly $107-110 Calls
$107 Calls – Range: 1.95-3.20 – Max Gain: 64%
$108 Calls – Range: 1.40-2.47 – Max Gain: 76%
$109 Calls – Range: .95-1.94 – Max Gain: 104%
$110 Calls – Range: .60-1.41 – Max Gain: 135%
_____

Fresh Idea:
DKS Weekly $34.50-36 Calls
LB 09/13 $20-21 Calls 

Extended Watchlist:
KIRK, CETX, PAYS, VIVE, PLX, JE

Blue Horseshoe Stocks: More Bottom-Plays

Seres Therapeutics, Inc. MCRB 

It was a pretty slow start to the week yesterday with the markets gapping up early, but falling into decline throughout the session. That didn’t stop the one fresh idea we did have in our morning report from posting a respectable performance on the day.

We referred to MCRB as a ‘prime bottom play’ and while it didn’t exactly explode out of the gate, what we did see was certainly a step in the right direction. From a low of 2.63, the stock ran a modest but solid 16% to a high of 3.06. More importantly, it preserved its momentum by holding the three-dollar mark into the close. A good first day by any stretch of the imagination.

We’ll continue to monitor our longer term options idea that we included, the MCRB 07/19 $2.50 Calls which stand to do well in coming weeks if the stock can continue to maintain the current trend. Yesterday’s session was the fourth consecutive day that the stock has recorded higher lows, and we’ll want to see more of that moving forward.

Verastem Inc. VSTM 

Speaking of bottom plays, we’ve got another one to add to our radars this morning in VSTM. This stock has lost a ton of value over the past year, and recently began to show signs of a rebound. We like it for its technical setup and volatility potential. We will remain interested in tracking VSTM for as long as it can maintain support at 1.72 or better.

VSTM is considered by some to be a speculative buyout play as well. Just this week the company has reported positive early stage data on Copiktra, the company’s leukemia treatment under development. Definitely an interesting story to follow.

____

Celestica Inc. CLS

Perhaps even more attractive as a bottom play than the above mentioned stock, we’ve got CLS, which just began to show signs of life after recording a new annual low at the beginning of this month.

If the stock can manage to break its 50DMA at 7.09, there’s a real chance that it could produce significant gains, filling the gap to the topside on the chart. Interesting to naote about CLS as well, is that the company’s EPS has grown by nearly 90% over the past year. When taking that into consideration, its current valuation doesn’t make a whole lot of sense.

Extended Watchlist:
CBAY, DERM, SAVA, NERV, NDRA, PHUN, VIVE

Blue Horseshoe Stocks: Prime Bottom Play

CarMax, Inc. KMX – Recap 

To open things up this week, we’re going to go over the performance of a fresh options ideas from Friday morning’s premarket report. We were tracking the  KMX Weekly $85-87.50 Calls and we met with some very good fortune in the form of multi-bag, single session gain opportunities.

All four of the contract sets we watching provided enormous intraday chances, which wasn’t surprising, given the huge help we had last week from a surge in the markets. A strong earnings report from KMX did the rest, and we finished out the week with these superb gains: 

$85 Calls – Range: .48-2.55 – Max Gain: 431%
$86 Calls – Range: .27-1.73 – Max Gain: 541%
$87 Calls – Range: .15-1.09 – Max Gain: 627%
$87.50 Calls – Range: .10-.76 – Max Gain: 660%

Fresh Ideas: 

Seres Therapeutics, Inc. MCRB 

We’re currently very interested in MCRB for multiple reasons. The stock recently touched down on a new annual low, and at the same time, a company director purchased a huge block of shares which amounted to a significant percentage of the overall market cap.

Since then the stock has been trending off of that bottom, with just the sort of volatility potential we’re always after. In addition to the stock itself being a solid candidate for a recovery play, we will also place the MCRB 07/19 $2.50 Calls on watch.

Extended Watchlist:
ACST, MEIP, VIVE, GSV, OBLN, BPMX, NBRV, CJJD